His main research concerns Cancer research, Cell biology, RNA interference, Signal transduction and Biochemistry. He has researched Cancer research in several fields, including Cancer cell, CD34 and Pharmacology. His Cell biology research includes elements of Exocytosis and Lysosome.
His research on RNA interference concerns the broader Genetics. His work deals with themes such as RNA, Interaction network and Transcription, which intersect with Signal transduction. His research on Endosome also deals with topics like
His primary areas of investigation include Cancer research, Cell biology, High-throughput screening, Pharmacology and Molecular biology. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Metastasis, Cell culture and In vivo. He studies Signal transduction, a branch of Cell biology.
The High-throughput screening study combines topics in areas such as Computational biology and Small molecule. His work in Computational biology addresses issues such as RNA interference, which are connected to fields such as Bioinformatics. His Pharmacology research is multidisciplinary, incorporating perspectives in Agonist and Receptor.
His scientific interests lie mostly in Cancer research, In vivo, Cell biology, Cancer cell and Agonist. His Cancer research study combines topics from a wide range of disciplines, such as Cell, Cell culture and Cancer, Ovarian cancer, Metastasis. His In vivo study also includes fields such as
His Cell biology study integrates concerns from other disciplines, such as Dermis, Human skin and Spongiosis. His Cancer cell research incorporates elements of Autophagy, Pancreatic cancer, Immune system, Autolysosome and Perinucleolar compartment. His research in Agonist intersects with topics in Biophysics, Pharmacology, Small molecule and Innate immune system.
Marc Ferrer mostly deals with Cancer research, Cell biology, Cancer cell, Autophagy and Skin equivalent. The study incorporates disciplines such as Tipifarnib, Secretion, ESCRT, Receptor and High-throughput screening in addition to Cancer research. Marc Ferrer combines subjects such as PI3K/AKT/mTOR pathway, Signal transduction, Pediatric cancer and Carcinogenesis with his study of Receptor.
Marc Ferrer undertakes multidisciplinary studies into Cell biology and GPR32 in his work. His biological study spans a wide range of topics, including Cell culture, In vitro, Immune system and RNA polymerase. His studies deal with areas such as Gating, Electrophysiology and Membrane potential as well as Autophagy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
Honglin Zhou;Min Xu;Qian Huang;Adam T. Gates.
Cell Host & Microbe (2008)
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yibin Yang;Arthur L. Shaffer;N.C. Tolga Emre;Michele Ceribelli.
Cancer Cell (2012)
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
Lesley A. Mathews Griner;Rajarshi Guha;Paul Shinn;Ryan M. Young.
Proceedings of the National Academy of Sciences of the United States of America (2014)
MCOLN1 is a ROS sensor in lysosomes that regulates autophagy
Xiaoli Zhang;Xiping Cheng;Lu Yu;Junsheng Yang;Junsheng Yang.
Nature Communications (2016)
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
Anju Singh;Sreedhar Venkannagari;Kyu H. Oh;Ya Qin Zhang.
ACS Chemical Biology (2016)
Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides.
James R. Maiolo;Marc Ferrer;Elizabeth A. Ottinger.
Biochimica et Biophysica Acta (2005)
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements
Marc Ferrer;Tarun M. Kapoor;Tim Strassmaier;Winfried Weissenhorn;Winfried Weissenhorn.
Nature Structural & Molecular Biology (1999)
A TRP Channel in the Lysosome Regulates Large Particle Phagocytosis via Focal Exocytosis
Mohammad Samie;Xiang Wang;Xiaoli Zhang;Andrew Goschka.
Developmental Cell (2013)
Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions
Steven R. Bartz;Zhan Zhang;Julja Burchard;Maki Imakura.
Molecular and Cellular Biology (2006)
Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption
Wei-Qin Zhao;Francesca Santini;Robert Breese;Dave Ross.
Journal of Biological Chemistry (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: